Glenview Trust’s NeoGenomics NEO Stock Holding History

Glenview Trust’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,986	Closed	-$103K	–	431
2022 Q3	$103K	Hold	11,986	–	–	﹤0.01%	402
2022 Q2	$98K	Buy	11,986 +135	+1%	+$1.29K	﹤0.01%	400
2022 Q1	$144K	Hold	11,851	–	–	﹤0.01%	414
2021 Q4	$404K	Hold	11,851	–	–	0.01%	325
2021 Q3	$572K	Sell	11,851 -2,155	-15%	-$99.8K	0.02%	249
2021 Q2	$633K	Buy	+14,006	New	+$621K	0.02%	233

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Glenview Trust's NEO Position: Q4 2022 in Review

Glenview Trust sold out of NeoGenomics (NEO) in Q4 2022, closing a stake of 11,986 shares — an estimated $103K sold.

Glenview Trust first reported a position in NEO in Q2 2021 and held it in 6 quarters. The position peaked at $633K in Q2 2021. 242 funds tracked by Wall St. Rank hold NEO as of Q4 2022.

Glenview Trust reported no remaining NeoGenomics position as of Q4 2022 after selling out during the quarter.
Glenview Trust sold 11,986 NeoGenomics shares in Q4 2022, an estimated $103K.
Glenview Trust first reported a position in NeoGenomics in Q2 2021 and held it in 6 quarters.
Glenview Trust's NeoGenomics position peaked at $633K in Q2 2021.
242 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2022.

Based on Glenview Trust's 13F filing for Q4 2022, filed 8 Feb 2023.